BridgeBio Oncology Therapeutics BBOT Growth Metrics (2025-2026)

NASDAQ BBOT
$3.92 +0.11 (+2.89%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

BridgeBio Oncology Therapeutics Quarterly Growth Metrics

Periods 6 quarters
Latest Jun 2026

BridgeBio Oncology Therapeutics growth metrics data for the quarter ended Jun 2026. These growth metrics cover 6 quarters of results from Mar 2025 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth Metrics Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
Return on Assets [ROA] Growth (1y)ROA Growth (1y) -1170.00-763.00-638.00
Return on Assets [ROA] (QoQ)ROA (QoQ) -1221.00-1282.00912.00421.00-814.00-1157.00
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y) -748.00-693.00-870.00
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ) -1009.00-1248.00818.00691.00-954.00-1425.00
Return on Equity [ROE] (QoQ)ROE (QoQ) 7,471.00-953.00-1464.00

BridgeBio Oncology Therapeutics Growth Metrics API

Pull BridgeBio Oncology Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=BBOT&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY